1. Home
  2. NATL vs TARS Comparison

NATL vs TARS Comparison

Compare NATL & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NCR Atleos Corporation

NATL

NCR Atleos Corporation

HOLD

Current Price

$37.74

Market Cap

2.7B

Sector

N/A

ML Signal

HOLD

Logo Tarsus Pharmaceuticals Inc.

TARS

Tarsus Pharmaceuticals Inc.

HOLD

Current Price

$80.00

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NATL
TARS
Founded
2023
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.8B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
NATL
TARS
Price
$37.74
$80.00
Analyst Decision
Buy
Strong Buy
Analyst Count
4
9
Target Price
$42.75
$76.56
AVG Volume (30 Days)
446.1K
376.9K
Earning Date
11-05-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.74
N/A
Revenue
$4,322,000,000.00
$366,100,000.00
Revenue This Year
$2.83
$147.24
Revenue Next Year
$3.96
$53.11
P/E Ratio
$21.33
N/A
Revenue Growth
0.63
182.44
52 Week Low
$22.30
$38.51
52 Week High
$42.23
$85.25

Technical Indicators

Market Signals
Indicator
NATL
TARS
Relative Strength Index (RSI) 57.85 61.12
Support Level $36.12 $77.44
Resistance Level $37.61 $85.25
Average True Range (ATR) 1.02 3.56
MACD 0.21 -0.27
Stochastic Oscillator 95.11 62.69

Price Performance

Historical Comparison
NATL
TARS

About NATL NCR Atleos Corporation

NCR Atleos Corp is financial technology company providing self-directed banking solutions to a customer base including financial institutions, merchants, manufacturers, retailers and consumers. Self-directed banking is a rapidly growing, secular trend that allows banking customers to transact seamlessly between various channels all for the same transaction. Their comprehensive solutions enable the acceleration of self-directed banking through ATM and interactive teller machine (ITM) technology, including software, services, hardware and its proprietary Allpoint network. Atleos manage its operations in the following segments which includes Self-Service Banking, Network, and Telecommunications abd Technology.

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

Share on Social Networks: